Somatic genetic analysis of cyclic AMP action: selection of unresponsive mutants.
Dibutyryl cyclic AMP and theophylline kill S49.1 mouse lymphoma tissue culture cells. When cells are grown in soft agar with these drugs, the few clones that survive are resistant to cytolysis. The rate of mutation to resistance is 1-3 times 10-7/cell/generation in both diploid and tetraploid cells. The incidence of mutants is increased by treatment with a chemical mutagen, ICR 191. The mutation is consistently associated with greatly reduced or absent cytoplasmic cyclic AMP binding protein. These results suggest that a somatic mutation leads to a defect of the protein kinase regulatory subunit and that activity of this kinase is required for induction of cell death by cyclic AMP.
D000818:Animals; D003994:Bucladesine / Q000494:pharmacology*; D002460:Cell Line; D002875:Chromosomes / Q000032:analysis; D002999:Clone Cells; D000242:Cyclic AMP / Q000378:metabolism / Q000502:physiology*; D004171:Diploidy; D004351:Drug Resistance; D008223:Lymphoma / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008967:Molecular Biology; D009154:Mutation; D011123:Polyploidy; D013806:Theophylline / Q000494:pharmacology
D003994:Bucladesine; D013806:Theophylline; D000242:Cyclic AMP